Literature DB >> 477047

Absolute bioavailability of digoxin in chronic renal failure.

E E Ohnhaus, S Vozeh, E Nüesch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 477047

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


× No keyword cloud information.
  6 in total

1.  Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal function.

Authors:  W Kirch; A Nokhodian; A Halabi; G Weidinger
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

Review 2.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 3.  Disease-related alterations in cardiac glycoside disposition.

Authors:  H R Ochs; D J Greenblatt; G Bodem; H J Dengler
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

4.  Comparison of two different loading doses of digoxin in severe renal impairment.

Authors:  E E Ohnhaus; H R Lenzinger; R L Galeazzi
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

6.  Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats.

Authors:  Kamal M Matar; Yasin I Tayem
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.